A pharmaceutical company based in Norway, Algeta were in the process of developing a new drug for cancer patients. To reflect their brand clearly and cohesively to potential new investors, August were tasked in updating their existing print and digital presence. I led the digital design while collaborating with print designers on our team to create a cohesive rebrand across all mediums.
On the face of it this was a very simple site, however we placed a lot of emphasis on the positioning and detail of how the content should look and feel, particularly in the balance of typography and inspirational imagery. In terms of user experience, a big challenge was to make sure there was a clear journey between our editorial, top level content, and more complex data like financial statistics and share value.
Algeta received a lot of additional interest after we went live with the project and around 6 to 8 months later they were fully acquired by Bayer AG for $2.9 billion.
